POST-FINASTERIDE SYNDROME FOUNDATION (EIN 460573960) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Principal Officer

JOHN SANTMANN

Tax Period

2023-01-01 to 2023-12-31

POST-FINASTERIDE SYNDROME FOUNDATION, founded in 2012, is a micro nonprofit in the Medical Research sector that reported $68K in total revenue in fiscal year 2023. Revenue surged 36% from the prior year, signaling strong growth momentum. Expenses of $85K exceeded revenue, resulting in a 25% operating deficit.

Mission

TO PROMOTE PUBLIC AND PROFESSIONAL AWARENESS OF THE POST-FINASTERIDE SYNDROME.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $67,901

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $67,901

Expense Breakdown

Grants Paid $43,500

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $43,500

Other Expenses $41,163

TOTAL EXPENSES $84,663

Year-over-Year Comparison

	2023	2022	Change
Revenue	$67,901	$49,812	+0.4%
Expenses	$84,663	$41,418	+1.0%
Net Income	$-16,762	$8,394	-3.0%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

$24,000

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
PHILIP RECCHIA	PRESIDENT	20.0	Director	$24,000	$0	$24,000
JOHN SANTMANN MD	CEO	3.0	Director	$0	$0	$0
ROSEMARY MCGEADY MD JD	GENERAL COUNSEL	2.0	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$67,901	$84,663	$16,960	$-16,762
2022	$49,812	$41,418	$33,722	$8,394
2021	$14,476	$55,855	$25,328	$-41,379
2020	$87,153	$40,158	$135,332	$46,995
2020	$87,153	$40,158	$135,332	$46,995
2019	$34,917	$74,642	$88,337	$-39,725
2018	$198,794	$169,227	$128,062	$29,567

POST-FINASTERIDE SYNDROME FOUNDATION